Health Quest NF is committed to transparency and FTC compliance, ensuring all content aligns with ethical standards to protect reader trust. This policy outlines how we disclose partnerships, sponsorships, and affiliate relationships that may influence our content. When we feature products, services, or research opportunities, we clearly identify any financial or non-financial relationships with third parties, including pharmaceutical companies, advocacy groups, or academic institutions. Our goal is to maintain credibility by separating editorial content from promotional material, ensuring readers can make informed decisions based on accurate, community-driven insights.
We participate in initiatives led by the Children’s Tumor Foundation, Global Genes, and Rare Patient Voice, which shape our content and community engagement strategies. However, we disclose any direct financial support or in-kind contributions from these organizations, as well as others, to avoid conflicts of interest. Sponsored content—including interviews, collaborations, or promotional materials—is labeled as such and reflects the perspectives of the involved parties, not necessarily those of Health Quest NF. This approach ensures readers understand the context of shared information, whether it originates from the patient community, researchers, or industry stakeholders.
All health-related information is curated through a patient-advocate lens, emphasizing lived experiences, research updates, and peer-reviewed findings. While we prioritize accuracy, we do not replace professional medical advice. Readers are encouraged to consult their healthcare providers for personalized guidance. Our content may include links to external resources, which are reviewed for relevance but not endorsed by Health Quest NF unless explicitly stated. These links are disclosed with clear disclaimers to maintain integrity and avoid misleading readers about our affiliations or biases.
Health Quest NF adheres to strict editorial guidelines to ensure content remains free from undue influence. When discussing treatments, therapies, or clinical trials, we highlight their developmental stage, potential risks, and availability, while avoiding language that could imply endorsement. Our team includes individuals with lived experience, researchers, and advocates, whose contributions are acknowledged to reinforce the collaborative nature of our work. Any changes to this policy will be posted on our Contact Us page, where readers can also reach out with questions or concerns about our disclosures.